Abiomed, Opsens to upgrade Impella device

Kaitlyn Dmyterko | | Cardiovascular Business | Interventional Cardiology
Impella heart pump manufacturer Abiomed has partnered with Opsens to integrate its fiber optic sensor into the Abiomed catheter to provide blood pressure measurements.

According to Danvers, Mass.-based Abiomed, the integration will provide a pressure monitoring capability that can help to operate the heart pump. In addition, the integration will provide control during "high-risk and emergent procedures."

Currently, the device is used in more than 1,600 U.S. patients and 3,000 worldwide.

Kaitlyn Dmyterko

Related Content

Cardiologists reflect on developing primary PCI in face of criticism and pushback
How TAVR valve choice impacts outcomes when treating type 1 bicuspid AS
IVUS-guided PCI reduces risks in patients with diabetes
Medtronic using AI to identify more TAVR patients in need
SAVR linked to higher 10-year survival rate than TAVR for low-risk patients
LAAC with Watchman FLX reduces bleeding risks after AFib ablation

Around the web

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Health Imaging
New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Radiology Business
What does radiology have to do with climate change?

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."